Shuming Chen

Research Associate

20122019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Shuming Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Mechanisms regulating PD-L1 expression on tumor and immune cells

Chen, S., Crabill, G. A., Pritchard, T. S., McMiller, T. L., Wei, P., Pardoll, D. M., Pan, F. & Topalian, S. L., Nov 15 2019, In : Journal for immunotherapy of cancer. 7, 1, 305.

Research output: Contribution to journalArticle

Open Access
  • Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: Implications for immunotherapy

    Duffield, A. S., Ascierto, M. L., Anders, R. A., Taube, J. M., Meeker, A. K., Chen, S., McMiller, T. L., Phillips, N. A., Xu, H., Ogurtsova, A., Berger, A. E., Pardoll, D. M., Topalian, S. L. & Ambinder, R. F., Jul 25 2017, In : Blood Advances. 1, 17, p. 1324-1334 11 p.

    Research output: Contribution to journalArticle

    Open Access
  • Differential expression of immune-regulatory genes associated with PD-L1 display in melanoma: Implications for PD-1 pathway blockade

    Taube, J. M., Young, G. D., McMiller, T. L., Chen, S., Salas, J. T., Pritchard, T. S., Xu, H., Meeker, A. K., Fan, J., Cheadle, C., Berger, A. E., Pardoll, D. M. & Topalian, S. L., Sep 1 2015, In : Clinical Cancer Research. 21, 17, p. 3969-3976 8 p.

    Research output: Contribution to journalArticle

  • PD-L1 expression in melanocytic lesions does not correlate with the BRAF V600E mutation

    Rodic, N., Anders, R. A., Eshleman, J. R., Lin, M. T., Xu, H., Kim, J. H., Beierl, K., Chen, S., Luber, B. S., Wang, H., LTopalian, S., Pardoll, D. M. & Taube, J. M., Feb 2015, In : Cancer Immunology Research. 3, 2, p. 110-115 6 p.

    Research output: Contribution to journalArticle

  • Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting

    Lipson, E. J., Sharfman, W. H., Chen, S., McMiller, T. L., Pritchard, T. S., Salas, J. T., Sartorius-Mergenthaler, S., Freed, I., Ravi, S., Wang, H., Luber, B., Sproul, J. D., Taube, J. M., Pardoll, D. M. & Topalian, S. L., Jul 5 2015, In : Journal of translational medicine. 13, 1, 214.

    Research output: Contribution to journalArticle